Reserpine is an alkaloid obtained from the roots of certain species of the genus Rauwolfia, sometimes spelled Rauvolfia (of the family Apocynaceae), mainly Rauwolfia serpentina and Rauwolfia vomitoria, or by synthesis. The material obtained from natural sources may contain closely related alkaloids. It has been used as an antihypertensive and an antipsychotic, such as for the treatment of schizophrenia, as well as a research tool, but its adverse effects limit its clinical use. It has also been used in the treatment of Raynaud's syndrome. It has also been used as a radioprotective agent and experimentally as a contraceptive.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Reserpine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.